PaxMedica Inc. Gains 47.71%
Fri, Sep 02, 2022 at 07:20 PM
PaxMedica Inc. (PXMD:NASDAQ) rocketted at $5.17, a gain of 47.7%. On Fri, Sep 02, 2022, PXMD:NASDAQ hit a New 2-Week High of $5.17. The stock appeared on our News Catalysts scanner on Mon, Aug 29, 2022 at 06:04 AM in the 'BIOTECH' category. From Fri, Aug 26, 2022, the stock recorded 60.00% Up Days and 0.00% Green Days
About PaxMedica Inc. (PXMD:NASDAQ)
PaxMedica Inc an early clinical stage biopharmaceutical company focusing on the development of anti-purinergic therapies (or APT), for the treatment of neurodevelopmental disorders, including autism...
Top 10 Gainers:
- Venus Concept Inc. (VERO:NASDAQ), 54.87%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- PaxMedica Inc. (PXMD:NASDAQ), 47.71%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 35.29%
- Sunrise New Energy Co. Ltd Ord (EPOW:NASDAQ), 31.46%
- Advanced Human Imaging Limited. (AHI:NASDAQ), 29.1%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 23.39%
- Pear Therapeutics Inc. (PEAR:NASDAQ), 21.71%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 21.38%
- New Age Beverages Corporation (NBEV:NASDAQ), 21.28%